[HTML][HTML] Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and …
MA Perales, I Ceberio, P Armand, LJ Burns… - Biology of Blood and …, 2015 - Elsevier
The role of hematopoietic cell transplantation (HCT) in the therapy of Hodgkin lymphoma
(HL) in pediatric and adult patients is reviewed and critically evaluated in this systematic …
(HL) in pediatric and adult patients is reviewed and critically evaluated in this systematic …
Management of relapsed and refractory classical Hodgkin lymphoma in children and adolescents
S Daw, R Wynn, H Wallace - British journal of haematology, 2011 - Wiley Online Library
There are a number of options for salvage treatment in children and adolescents with
relapsed and refractory classical Hodgkin Lymphoma. These include salvage with standard …
relapsed and refractory classical Hodgkin Lymphoma. These include salvage with standard …
A prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin lymphoma
Autologous hematopoietic cell transplantation (AutoHCT) is a potentially curative treatment
modality for relapsed/refractory Hodgkin lymphoma (HL). However, no large studies have …
modality for relapsed/refractory Hodgkin lymphoma (HL). However, no large studies have …
Survival by race and ethnicity in pediatric and adolescent patients with Hodgkin lymphoma: a children's oncology group study
PURPOSE Population-based studies of children and adolescents with Hodgkin lymphoma
(HL) report a survival disadvantage in nonwhite—non-Hispanic black (NHB) and Hispanic …
(HL) report a survival disadvantage in nonwhite—non-Hispanic black (NHB) and Hispanic …
Stratification of treatment intensity in relapsed pediatric Hodgkin lymphoma
PD Harker‐Murray, RA Drachtman… - Pediatric Blood & …, 2014 - Wiley Online Library
Risk‐adapted, response‐based therapies for pediatric Hodgkin lymphoma have resulted in
5‐year survival exceeding 90%. Although high‐dose chemotherapy and autologous …
5‐year survival exceeding 90%. Although high‐dose chemotherapy and autologous …
Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: the Memorial Sloan …
L Giulino-Roth, T O'Donohue, Z Chen… - Leukemia & …, 2018 - Taylor & Francis
To evaluate outcomes and prognostic markers among children with relapsed Hodgkin
lymphoma (HL) treated with autologous stem cell transplant (ASCT), we conducted a …
lymphoma (HL) treated with autologous stem cell transplant (ASCT), we conducted a …
[HTML][HTML] Outcome and toxicity of ifosfamide, carboplatin, and etoposide versus gemcitabine and vinorelbine regimen for pediatric patients with relapsed or refractory …
Background Pediatric classical Hodgkin lymphoma (CHL) is a curable disease; however, the
optimal salvage regimen is unclear for relapsed/refractory (R/R) disease. This study aimed …
optimal salvage regimen is unclear for relapsed/refractory (R/R) disease. This study aimed …
Clinical features and prognostic factors of primary bone marrow lymphoma
G Wang, Y Chang, X Wu, X Li, L Li… - Cancer Management …, 2019 - Taylor & Francis
Background Primary bone marrow lymphoma (PBML) is a very uncommon neoplasm
originally arising in the bone marrow system, and the most common pathological type is …
originally arising in the bone marrow system, and the most common pathological type is …
Ifosfamide, gemcitabine, and vinorelbine is an effective salvage regimen with excellent stem cell mobilization in relapsed or refractory pediatric Hodgkin lymphoma
Abstract We describe 12 pediatric patients (8‐16 years) with primary refractory (N= 6) or first
relapse (N= 6) Hodgkin lymphoma (HL) treated with ifosfamide, gemcitabine, and …
relapse (N= 6) Hodgkin lymphoma (HL) treated with ifosfamide, gemcitabine, and …
Outcome of pediatric patients with lymphoma following stem cell transplant: a single institution report
H Sumaili, A Al-Kofide, A Al-Seraihi, M Ayas… - Leukemia & …, 2015 - Taylor & Francis
Hematopoietic stem cell transplant (HSCT) is recommended for pediatric patients with
relapsed/refractory lymphoma even though the evidence for this is limited. We …
relapsed/refractory lymphoma even though the evidence for this is limited. We …